Castle Biosciences Inc
NASDAQ:CSTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Castle Biosciences Inc
NASDAQ:CSTL
|
US |
|
T
|
Thai Setakij Insurance PCL
SET:TSI
|
TH |
|
Idea Consultants Inc
TSE:9768
|
JP |
|
L
|
LDR Turizm AS
IST:LIDER.E
|
TR |
|
Reliance Steel & Aluminum Co
NYSE:RS
|
US |
|
W
|
WeRide Inc
NASDAQ:WRD
|
CN |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
Wall Street
Price Targets
CSTL Price Targets Summary
Castle Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
CSTL
is 49.47 USD
with a low forecast of 44.44 USD and a high forecast of 54.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CSTL's stock price target?
Price Target
49.47
USD
According to Wall Street analysts, the average 1-year price target for
CSTL
is 49.47 USD
with a low forecast of 44.44 USD and a high forecast of 54.6 USD.
What is Castle Biosciences Inc's Revenue forecast?
Projected CAGR
8%
For the last 7 years the
compound annual growth rate for
Castle Biosciences Inc's revenue is
47%.
The projected
CAGR
for the next 3 years is
8%.
